MAPT and Alzheimer disease: This is in line with clinical observations where pre-symptomatic AD patients present with hippocampal hyperactivity, as well as preclinical findings in AD mouse models where neurons in the vicinity of Aβ plaques are hyperactive, a behavioural phenotype that has been found to require tau [24–26].